Sonal Shah

Sonal Shah currently serves as the Division Head - Biosciences at SHILPA MEDICARE LTD since November 2023 and holds the position of Head Marketing - Biosimilars at Cadila Pharmaceuticals Limited since April 2021. Previous experience includes a role as Marketing Manager at Intas Pharmaceuticals from October 2017 to April 2021, where notable achievements involved managing a super speciality Rheumatology Biologic Division, handling three biologics, and launching the world's first biosimilar Denosumab. Sonal is proficient in implementing cost-saving initiatives, forecasting sales and profit numbers, and developing innovative marketing strategies to enhance business operations and customer engagement. Education includes a Postgraduate Degree in Business Administration and Management from Symbiosis Centre for Distance Learning and a degree in Biochemistry from Fridaus Amrut Higher Secondary School.